Related Experiment Video
Updated: Apr 25, 2026

06:08
Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
2.8K
Adipocyte transdifferentiation and its molecular targets.
Sujith Rajan1, Abhishek Gupta2, Muheeb Beg2
1Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031 UP, India; Academy of Scientific and Innovative Research, CSIR-CDRI, India.
Differentiation; Research in Biological Diversity
|August 19, 2014
Summary
Brown adipose tissue (BAT) offers a novel therapeutic strategy for obesity by utilizing fatty acids for energy expenditure. Understanding BAT
Area of Science:
- Metabolic science and endocrinology, focusing on adipose tissue biology.
Background:
- Obesity, defined as excessive fat accumulation, elevates risks for metabolic disorders like insulin resistance, dyslipidemia, and cardiovascular diseases.
- Adipose tissue comprises white adipose tissue (WAT) and brown adipose tissue (BAT), with BAT gaining significant scientific attention.
Purpose of the Study:
- To explore the therapeutic potential of brown adipose tissue (BAT) for obesity and related metabolic disorders.
- To investigate the mechanisms of BAT activation and the browning of white adipocytes.
Main Methods:
- Review of current scientific literature on adipose tissue biology, BAT function, and therapeutic strategies.
- Analysis of molecular pathways and differentiation factors involved in adipocyte transdifferentiation.
Main Results:
- BAT's ability to expend energy by utilizing accumulated fatty acids presents a potential alternative to current obesity treatments.
- The browning of white adipocytes, induced by cold exposure or pharmacological agents, demonstrates the feasibility of transdifferentiation.
Conclusions:
- Targeting BAT and understanding its molecular pathways are crucial for developing novel therapeutic strategies against obesity and metabolic syndrome.
- Further research into the factors driving adipocyte transdifferentiation can lead to innovative treatments for metabolic disorders.

